Medical and Pharmaceutical Industry - Market Research Report

The global   neglected tropical diseases (NTDs) diagnosis market   size was valued at USD 6.84 billion in 2024 and is projected to reach USD 9.59 billion by 2030, expanding at a CAGR of 6.03% from 2025 to 2030. Market growth is primarily driven by rising awareness of NTDs and increasing government-led initiatives aimed at disease control and elimination. For instance, the inclusion of NTDs in the United Nations Development Program’s Sustainable Development Goals (SDG) highlights the global commitment to combat these diseases. Similarly, the World Health Organization’s (WHO) “road map 2030” initiative for the elimination of NTDs is anticipated to fuel growth throughout the forecast period. However, the outbreak of the COVID-19 pandemic caused notable disruptions to the NTD diagnosis market. According to WHO’s pulse survey in early 2021, 44% of countries reported interruptions to their NTD programs due to the pandemic. Resource diversion to COVID-19, reduced health budgets in lo...

The global   needle holders market   size was estimated at USD 231.83 million in 2022 and is projected to reach USD 505.50 million by 2030, growing at a CAGR of 10.25% from 2023 to 2030. Growth is driven by the rising prevalence of surgical procedures worldwide, advancements in minimally invasive techniques requiring precise instrument control, the increasing geriatric population leading to greater demand for surgical interventions, and continuous innovations in needle holder designs that improve surgical efficiency. The market is also supported by expanding healthcare infrastructure in emerging economies, improved access to quality medical services, and the growing focus on enhancing patient outcomes. Rising incomes in developing countries are boosting affordability for advanced medical procedures, thereby contributing to increased demand for surgical instruments, including needle holders. Technological innovations are further shaping the market, with manufacturers designing ...

  The global   needle-free drug delivery devices market   size was valued at USD 13.2 billion in 2023 and is projected to reach USD 21.6 billion by 2030, growing at a CAGR of 7.5% from 2024 to 2030. The rising prevalence of diabetes worldwide and the increasing demand for convenient glucose monitoring devices are key factors driving market growth. Traditionally, type 1 diabetes patients relied on needles for glucose monitoring, which was often painful and carried the risk of infections. Needle-free devices provide a painless and safer alternative, resulting in their rapid adoption during the forecast period. Additionally, technological advancements in drug administration and transportation are significantly contributing to market expansion. For example, in November 2023, Becton, Dickinson and Company (BD) introduced the PIVO Pro Needle-free Blood Collection Device after receiving clearance from the U.S. FDA. Government initiatives aimed at reducing the incidence of infect...

The global   near infrared imaging market   size was estimated at USD 2.24 billion in 2024 and is projected to reach USD 2.82 billion by 2030, growing at a CAGR of 3.9% from 2025 to 2030. The rising incidence of target diseases, such as cardiovascular diseases (CVDs), gastrointestinal, neurovascular conditions, and cancer, is expected to drive the demand for near infrared imaging over the coming years. According to the WHO, CVDs account for about 17.9 million deaths globally each year. In addition, the growing demand for technologically advanced fluorescence imaging systems and strategic initiatives by key market players are further fueling market expansion. For instance, in May 2024, Hamamatsu Photonics K.K., headquartered in Hamamatsu City, Japan, acquired NKT Photonics A/S, thereby strengthening its position in lasers, detectors, and advanced photonics solutions. The COVID-19 pandemic temporarily impacted the market for near infrared imaging as healthcare facilities shifted...

The global   minimally invasive thoracic surgery market   size was valued at USD 4.22 billion in 2023 and is expected to reach USD 6.24 billion by 2030, growing at a CAGR of 5.8% between 2024 and 2030. The rising prevalence of lung cancer is driving the demand for advanced patient care solutions, contributing to the steady expansion and transformation of the market. Market expansion is also fueled by evolving patient expectations, which emphasize improved care, routine monitoring, enhanced hospital-patient interactions, and seamless post-operative recovery. According to the American Cancer Society, lung cancer is responsible for nearly one in five cancer-related deaths globally. With advances in surgical techniques, minimally invasive thoracic surgery is playing a vital role in improving survival outcomes and reducing recovery times. Technological innovations, including the use of robotic-assisted systems such as Da Vinci instruments in laparoscopic procedures, are further acc...

The global   military actuators market   size was valued at USD 1.1 billion in 2019 and is anticipated to reach USD 1.7 billion by 2027, growing at a CAGR of 5.2% from 2020 to 2027. Military and defense applications demand high force in compact spaces, along with precise control of force, position, and speed. Actuators are essential in modern defense systems, fulfilling requirements for force, precision, and reliability. Rising terrorist activities, growing security concerns, political instability, and the implementation of advanced military programs are expected to drive demand for military actuators during the forecast period. Furthermore, ongoing technological advancements are pushing manufacturers to develop high-performance solutions for a wide range of military applications. The U.S. market benefits from rapid adoption of advanced technologies, robust R&D initiatives, and the presence of leading multinational companies such as Curtiss-Wright, Moog Inc., Parker Hannif...

The global   microwave devices market   size was estimated at USD 7.49 billion in 2022 and is projected to reach USD 11.86 billion by 2030, growing at a CAGR of 5.9% from 2023 to 2030. The increasing adoption of SiC and GaN devices in next-generation amplifier technologies is expected to propel market growth. Microwave devices are valued for their high efficiency, heat tolerance, and reliable performance even in harsh environments. Advanced microwave technologies with improved accuracy are increasingly deployed in telecommunications, offering high bandwidth that enables rapid data transmission. These devices also play a vital role in generating, amplifying, detecting, and measuring microwaves across applications. In the U.S., the microwave devices market is expected to witness consistent growth from 2023 to 2030. Asia Pacific remains a key growth driver, particularly with the expansion of telecom networks such as 4G, which demand microwave-emitting hardware in network towers. ...

The   North America and Europe intravenous infusion pumps market   was valued at USD 4.45 billion in 2024 and is projected to expand at a CAGR of 8.10% from 2025 to 2030. This notable growth is driven by the rising incidence of chronic illnesses such as diabetes, cancer, cardiovascular diseases, respiratory diseases, and stroke, with cardiovascular diseases remaining the leading cause of death in both regions. For instance, according to the U.S. Department of Health and Human Services, around 129 million Americans suffer from at least one major chronic condition. Intravenous infusion pumps are essential in the delivery of controlled, regulated, and error-free doses of medication or nutrients, especially during chemotherapy and radiation therapy, where dosage accuracy is critical. These systems significantly reduce the risk of medication errors—an area of major concern in chronic disease management. With the increasing demand for safer and more efficient delivery systems, next-...

The   Mexico veterinary medicine market   was estimated at USD 1.65 billion in 2024 and is expected to grow at a CAGR of 8.37% from 2025 to 2030. The market's growth is primarily driven by an increase in livestock population, rising pet ownership, growing incidence of zoonotic and chronic diseases, increased R&D investment, strategic initiatives by key industry players, and a surge in meat and dairy product consumption. Over recent decades, Mexico has seen a steady rise in its livestock population, which further supports market expansion. According to a USDA report dated September 5, 2024, the number of calf crops in Mexico is projected to reach 8.7 million in 2025, reflecting a 1% increase from 2024. This growth is attributed to increased export volumes and falling feed prices observed during 2023 and 2024. Moreover, pet os and cats—along with related supplies and medicines, is rising due to changing consumer lifestyles. Dogs represent 69.8% of all companion animals in Me...

The global   non-steroidal anti-inflammatory drugs (NSAIDs) market   size was estimated at USD 22.58 billion in 2024 and is projected to reach USD 31.29 billion by 2030, growing at a CAGR of 5.66% from 2025 to 2030. This growth is primarily fueled by the increasing prevalence of chronic pain conditions and a steadily rising geriatric population worldwide. The market is further supported by the expanding demand for over-the-counter (OTC) NSAIDs and their broad applications in treating common ailments such as headaches, migraines, dental pain, and menstrual discomfort. A wide-ranging NSAIDs product portfolio, along with new product approvals and launches, is expected to continue driving market momentum through the forecast period. The prevalence of arthritis and related pain disorders is a key growth factor. As of 2024, nearly one-quarter of U.S. adults are estimated to have arthritis, contributing to over 350 million cases globally. Among these, osteoarthritis affects more than...

The global   non-invasive prenatal testing (NIPT) market   was valued at USD 4.21 billion in 2023 and is projected to reach USD 8.16 billion by 2030, expanding at a compound annual growth rate (CAGR) of 10.06% from 2024 to 2030. This growth is driven by increasing demand for NIPT, a rise in strategic collaborations and licensing agreements, and improvements in the reimbursement landscape. A key factor contributing to the market expansion is the growing incidence of chromosomal abnormalities, which has heightened the need for early and accurate prenatal screening. Although the COVID-19 pandemic caused minor disruptions, most manufacturers maintained close communication with the U.S. FDA to mitigate supply chain issues and ensure service continuity. Among global markets, China represents a significant growth opportunity, with approximately 14.65 million annual births and a rising number of high-risk pregnancies. India also experiences a substantial burden of genetic disorders. S...